News > Even with Pfizer's success, India's best bet are Bharat Biotech, AstraZeneca

Even with Pfizer's success, India's best bet are Bharat Biotech, AstraZeneca

Unlike Pfizer, these two vaccine candidates are undergoing trials in India and will be available for the masses in the country as soon as tests are successfully completed, officials said.

A government official told the daily that India will focus on these two vaccines as they are being tested on the Indian population and hence has a major advantage over other potential candidates.